Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Aclarion, Inc. (ACON : NSDQ)

• Company Description    Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA. Number of Employees: 6

• Price / Volume Information    Yesterday's Closing Price: $7.72 Daily Weekly Monthly 20 Day Moving Average: 8,636 shares Shares Outstanding: 0.58 (millions) Market Capitalization: $4.50 (millions) Beta: 1.36 52 Week High: $2,157.23 52 Week Low: $6.20 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 7.78% 5.89% 12 Week 5.32% -4.33% Year To Date -99.41% -99.49%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8181 Arista Place Suite 100 - Broomfield,Co 80021 USA ph: 833-275-2266 fax: - None http://www.aclarion.com

• General Corporate Information    Officers Brent Ness - President; Chief Executive Officer and Director Jeffrey Thramann - Executive Chairman and Director John Lorbiecki - Chief Financial Officer Stephen Deitsch - Director David Neal - Director Peer Information Aclarion, Inc. (CHCR) Aclarion, Inc. (ESRX) Aclarion, Inc. (MYDP) Aclarion, Inc. (COR) Aclarion, Inc. (GBCS) Aclarion, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 655187409 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/13/25 Share - Related Items Shares Outstanding: 0.58 Most Recent Split Date: 3.00 (0.04:1) Beta: 1.36 Market Capitalization: $4.50 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-2.62 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-14.10 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.32 Price/Cash Flow: - Price / Sales: 72.24 EPS Growth vs. Year Ago Period: 99.80% vs. Previous Quarter: 70.49% Sales Growth vs. Year Ago Period: 72.73% vs. Previous Quarter: 0.00% ROE 06/30/25 - -83.63 03/31/25 - -126.89 12/31/24 - -366.75 ROA 06/30/25 - -76.55 03/31/25 - -106.61 12/31/24 - -230.66 Current Ratio 06/30/25 - 23.83 03/31/25 - 21.68 12/31/24 - 0.71 Quick Ratio 06/30/25 - 23.83 03/31/25 - 21.68 12/31/24 - 0.71 Operating Margin 06/30/25 - -11,238.59 03/31/25 - -12,227.10 12/31/24 - -15,460.29 Net Margin 06/30/25 - -11,238.59 03/31/25 - -12,227.10 12/31/24 - -15,460.29 Pre-Tax Margin 06/30/25 - -11,238.59 03/31/25 - -12,227.10 12/31/24 - -15,293.94 Book Value 06/30/25 - 24.37 03/31/25 - 27.10 12/31/24 - 51.50 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©